long-time period survival finished in metastatic melanoma with customized vaccine
two patients with cancer that had spread to the liver survived for as a minimum 8.five and 12 years after resection of the hepatic tumor and treatment with patient–specific immunotherapeutic vaccines. The vaccines, designed to spark off the immune system